Literature DB >> 12371636

Fire and ICE: the role of pyrin domain-containing proteins in inflammation and apoptosis.

D L Gumucio1, A Diaz, P Schaner, N Richards, C Babcock, M Schaller, T Cesena.   

Abstract

The genetic bases for several human autoinflammatory syndromes have recently been identified, and the mutated proteins responsible for these diseases are rapidly being characterized. Here, we examine two of these newly identified proteins, pyrin (also called marenostrin, product of the familial Mediterranean fever locus, MEFV) and cryopyrin (product of the CAIS1 locus, and mutated in familial cold urticaria, Muckle Wells syndrome and chronic infantile neurological cutaneous and articular syndrome). Both pyrin and cryopyrin contain an N-terminal domain that encodes a death domain-related structure, now known as the pyrin domain, or PyD. We trace the molecular interactions mediated by these PyDs, examine the evolution of the family of molecules containing this domain, and discuss the function of PyD-containing proteins and their homologues. Synthesis of the available data indicates that both pyrin and cryopyrin interact via their PyDs with a common adaptor protein, ASC. ASC itself participates in at least three important cellular processes: apoptosis, recruitment and activation of pro-caspase-1 (with associated processing and secretion of IL-1beta), and activation of NF-kappaB (a transcription factor involved in both initiation and resolution of the inflammatory response). Through PyD:PyD interactions, pyrin and cryopyrin, as well as several related, but still uncharacterized PyD containing proteins, appear to modulate the activity of all three of these processes, each of which plays a crucial role in the inflammatory pathways that characterize the innate immune system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12371636

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  25 in total

Review 1.  Behçet's syndrome: an update.

Authors:  Hasan Yazici
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

Review 2.  The death domain superfamily in intracellular signaling of apoptosis and inflammation.

Authors:  Hyun Ho Park; Yu-Chih Lo; Su-Chang Lin; Liwei Wang; Jin Kuk Yang; Hao Wu
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

Review 3.  The PYRIN domain in signal transduction.

Authors:  Christian Stehlik
Journal:  Curr Protein Pept Sci       Date:  2007-06       Impact factor: 3.272

4.  High frequency of MEFV gene mutations in patients with myeloid neoplasm.

Authors:  Cagatay Oktenli; Ozkan Sayan; Serkan Celik; Alev A Erikci; Yusuf Tunca; Hakan M Terekeci; Elcin Erkuvan Umur; Yavuz S Sanisoglu; Deniz Torun; Fatih Tangi; Burak Sahan; Selim Nalbant
Journal:  Int J Hematol       Date:  2010-05-01       Impact factor: 2.490

5.  Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene.

Authors:  E Rabinovich; A Livneh; P Langevitz; N Brezniak; E Shinar; M Pras; Y Shinar
Journal:  Ann Rheum Dis       Date:  2005-07       Impact factor: 19.103

Review 6.  Familial Mediterranean fever.

Authors:  Fatos Onen
Journal:  Rheumatol Int       Date:  2005-11-10       Impact factor: 2.631

7.  Expression and regulation of the NALP3 inflammasome complex in periodontal diseases.

Authors:  N Bostanci; G Emingil; B Saygan; O Turkoglu; G Atilla; M A Curtis; G N Belibasakis
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

Review 8.  CAPS and NLRP3.

Authors:  Laela M Booshehri; Hal M Hoffman
Journal:  J Clin Immunol       Date:  2019-05-10       Impact factor: 8.317

9.  1Novel MEFV transcripts in Familial Mediterranean fever patients and controls.

Authors:  Myrna Medlej-Hashim; Nancy Nehme; Eliane Chouery; Nadine Jalkh; André Megarbane
Journal:  BMC Med Genet       Date:  2010-06-09       Impact factor: 2.103

Review 10.  Familial mediterranean fever: revisiting an ancient disease.

Authors:  Seza Ozen
Journal:  Eur J Pediatr       Date:  2003-05-16       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.